Latest filing published 05 Feb 2026 for TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED, €5.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -23.1%Entry US$3.38 · Close 22 Oct 2026 US$2.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jinhushen Biological Medical Science and Technology Co., Ltd.: trading record in brief
Our data holds just one disclosure by Jinhushen Biological Medical Science and Technology Co., Ltd., dated 5 February 2026, reporting an open-market purchase worth €5 in Tianjin Pharmaceutical da REN Tang Group Corporation Limited. Further filings will be added here. Source: insider filings from SGX. Past trades are no guide to future returns.
Companies and markets linked to Jinhushen Biological Medical Science and Technology Co., Ltd.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8 shares@ SGD 1.00100.0% of flowShareSGX-STISIN CNE100000924SGX:NTGH7M4XYRFTTVKMCanonical exit: 5 May 2026 (T+90)
1 of 1 declaration